News

GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...
A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase ...
Altimmune said on Thursday its experimental obesity drug met the main goal of a mid-stage trial studying it as a potential treatment for a fatty liver disease.
Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...
Eli Lilly said on Thursday that India's drug regulator had approved the launch of pre-filled injector pens of its blockbuster ...
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...
UK health officials have launched a study into side-effects of weight loss drugs including Ozempic, Mounjaro and Wegovy ...
Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...
Weight loss drugs Mounjaro and Wegovy, as well as diabetes jab Ozempic may be linked to life-threatening health problems ...
As the markets for weight-loss drugs develop, pharma companies are having to adapt in search of the next big thing.
Around 1.5 million Brits are thought to be taking some form of weight loss drug, but there have been concerns over their link to pancreatitis and long-term side effects ...